These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


2348 related items for PubMed ID: 31294972

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Exploring the artificial intelligence and machine learning models in the context of drug design difficulties and future potential for the pharmaceutical sectors.
    Shiammala PN, Duraimutharasan NKB, Vaseeharan B, Alothaim AS, Al-Malki ES, Snekaa B, Safi SZ, Singh SK, Velmurugan D, Selvaraj C.
    Methods; 2023 Nov; 219():82-94. PubMed ID: 37778659
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Artificial intelligence in drug discovery: recent advances and future perspectives.
    Jiménez-Luna J, Grisoni F, Weskamp N, Schneider G.
    Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453
    [Abstract] [Full Text] [Related]

  • 7. Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review.
    Tripathi N, Goshisht MK, Sahu SK, Arora C.
    Mol Divers; 2021 Aug; 25(3):1643-1664. PubMed ID: 34110579
    [Abstract] [Full Text] [Related]

  • 8. Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.
    Hudson IL.
    Methods Mol Biol; 2021 Aug; 2190():167-184. PubMed ID: 32804365
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M, Pandi MT, Patrinos GP.
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [Abstract] [Full Text] [Related]

  • 12. New avenues in artificial-intelligence-assisted drug discovery.
    Cerchia C, Lavecchia A.
    Drug Discov Today; 2023 Apr; 28(4):103516. PubMed ID: 36736583
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A Review on Artificial Intelligence Approaches and Rational Approaches in Drug Discovery.
    Srivathsa AV, Sadashivappa NM, Hegde AK, Radha S, Mahesh AR, Ammunje DN, Sen D, Theivendren P, Govindaraj S, Kunjiappan S, Pavadai P.
    Curr Pharm Des; 2023 Jun 06; 29(15):1180-1192. PubMed ID: 37132148
    [Abstract] [Full Text] [Related]

  • 16. Structure-Based Drug Discovery with Deep Learning.
    Özçelik R, van Tilborg D, Jiménez-Luna J, Grisoni F.
    Chembiochem; 2023 Jul 03; 24(13):e202200776. PubMed ID: 37014633
    [Abstract] [Full Text] [Related]

  • 17. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
    Kashyap K, Siddiqi MI.
    Mol Divers; 2021 Aug 03; 25(3):1517-1539. PubMed ID: 34282519
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Generative machine learning for de novo drug discovery: A systematic review.
    Martinelli DD.
    Comput Biol Med; 2022 Jun 03; 145():105403. PubMed ID: 35339849
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 118.